It sounds like a movie script: A substance discovered under a stone statue on Easter Island turns out to be the most potent anti-aging agent mankind has found so far. Now, Rapamycin is conquering veterinary medicine. The "Dog Aging Project" in the USA is testing whether it can give our dogs more healthy years.
Rapamycin (Sirolimus) is technically an antibiotic and antifungal agent, which is mainly used in human medicine to prevent organ rejection. However, researchers discovered a fascinating "side effect": In almost every organism tested so far – from yeast to worms to mice – Rapamycin extended lifespan by 20 to 30%.
The Master Switch: mTOR
To understand Rapamycin, one must understand mTOR (mechanistic Target of Rapamycin). mTOR is a protein complex in cells that acts as a sensor for nutrients.
- Much food/protein: mTOR is ON. The cell grows, divides, builds mass. (Bodybuilding mode)
- Little food/fasting: mTOR is OFF. The cell pauses growth and starts repair mechanisms. (Maintenance mode)
The problem with our domestic dogs: Due to constant feeding, treats, and insufficient exercise, mTOR is permanently "ON". The cells grow, but they no longer repair themselves. They age faster and accumulate waste.
Rapamycin simulates fasting
Rapamycin acts like a chemical switch. It suppresses mTOR even if the animal eats. It signals the cell: "Times are tough, repair yourself!"
This activates Autophagy ("self-eating"). The cell begins to break down defective proteins and old organelles and recycle them. It is practically a comprehensive cellular cleaning service.
The Dog Aging Project: TRIAD
At the University of Washington, the TRIAD study (Test of Rapamycin in Aging Dogs) is currently underway. Hundreds of senior dogs are receiving low-dose Rapamycin. First results from preliminary studies are promising:
- Improved heart function (the heart muscle contracted better).
- No significant side effects at the low, intermittent dosage used.
- Owners reported increased activity and playfulness.
Is it available?
Rapamycin is a prescription drug. Currently, it is used "off-label" by specialized longevity veterinarians. It is not a dietary supplement.
Crucially, the dosage for anti-aging is completely different from that for organ transplantation. While high doses suppress the immune system (immunosuppression), low, pulsed doses (e.g., once a week) seem to rejuvenate the immune system.
Conclusion
Rapamycin is arguably the most exciting molecule in modern biogerontology. While we are still waiting for the final long-term data from the Dog Aging Project, it points to a future where we can treat aging pharmacologically. Until then, we can mimic the "mTOR brake" naturally: Through calorie restriction, intermittent fasting, and reducing inflammatory factors.